Two recent studies suggest that Long COVID may involve long-term neurobiological remodeling - even after mild infection.
One examined the brain under cognitive load.
The other looked at it at rest.
Together, they point to a persistent shift in network organization!🧵
In the first study (Barnden et al.), the key issue was not where the brain activates -
but how its networks coordinate under mental exertion.
The largest differences appeared during cognitive load.
The regulatory switching system began to fail.
The main systems involved were
the salience network - deciding what matters, and executive control circuits - sustaining performance.
And after repeated cognitive effort, the disruption became more pronounced.
That matches the lived experience
I can manage for a while - then it falls apart.
Now we have another study.
Hedström et al., Scientific Reports 2026.
Patients after mild infection.
No hospitalization.
And on average 32 months post-infection (sic!)
This is no longer early recovery.
This is long-term.
This time, the researchers looked at the brain at rest.
And they found something striking.
Increased connectivity in the Default Mode Network (DMN).
The DMN is active during internal thought, self-reference, mental simulation -
the brain’s baseline mode.
Patients showed higher intra-network DMN connectivity than controls.
Nearly 3 years after infection.
No structural abnormalities on conventional MRI.
So this is not visible damage.
It is altered network organization.
Interestingly, after a cognitive task, the group difference disappeared.
That could reflect
altered anticipation of task demands
disrupted switching between rest and task modes
or changes in returning to baseline
The authors remain cautious. But the pattern is there.
Barnden showed that under cognitive load, regulatory switching breaks down.
Hedström shows that the resting baseline itself is altered - long term.
These are not contradictions.
They are two sides of the same picture.
The simplest integrated model?
The baseline state is shifted.
And when regulatory demand increases, the switching system cannot compensate.
In other words - the brain starts from a different resting configuration,
and the transition between rest and effort becomes fragile.
What makes this particularly important?
These findings are present nearly three years after a mild infection!
That suggests persistent network remodeling.
Not a transient after-effect.
We are not seeing massive structural destruction.
We are seeing -
reorganization of networks
altered switching dynamics
increased energetic costs
reduced regulatory resilience under load
Even in people who were never hospitalized.
This also fits a broader framework seen in other chronic (!) post-infectious and inflammatory conditions, where regulatory brain networks gradually reorganize under prolonged physiological stress.
Subtle.
But persistent.
What is most concerning is not simply the presence of network differences -
but their persistence.
Nearly three years after a mild infection, the brain’s resting architecture remains measurably altered.
That shifts the conversation.
This is not just about recovery time.
It is about long-term neurobiological remodeling.
@szupraha @ZdravkoOnline @adamvojtech86 @adamkova_vera
Hedström et al., Brain connectivity and its relation to cognitive function in patients with post-COVID-19 condition after mild infection, Scientific Reports 2026. nature.com/articles/s4159…
If these network changes persist nearly three years after mild infection, the key question becomes - what maintains the shift away from baseline?
Across Long COVID biology, proposed drivers include persistent viral antigens or proteins and chronic immune dysregulation.
Ongoing low-grade neuroimmune signaling can alter synaptic efficiency, network synchronization, and energetic balance - especially in regulatory systems like the salience and executive networks.
That makes long-term remodeling biologically plausible.
Similar network-level cognitive patterns are seen in other chronic infections, including HIV-associated neurocognitive syndrom. HAND.
This does not mean the diseases are the same - but it suggests a shared vulnerability of brain control networks under sustained inflammatory stress.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Rather than framing long COVID as a simple state of persistent systemic inflammation, this new study points toward a model of chronically dysregulated immunity in which NK-cell dysfunction may occupy a central mechanistic role🧵
This paper says something important. In at least a subset of patients, long COVID may represent a state of impaired, inefficient, and partly exhausted immune surveillance, with NK cells at its center.
The authors support this with three layers of evidence. SARS-CoV-2 antibodies persist in the blood, while key cytokines fall, NK/NKT cells are reduced in number, and the NK cells that remain carry transcriptional signatures of functional remodeling and suppression.
A new PET study in patients with treatment-resistant depression suggests something important - ketamine does not just act generally on glutamate - it appears to reshape AMPA receptor density in specific brain circuits. @DavidJoffe64 🧵
The researchers used [11C]K-2, a tracer that can visualize AMPA receptors in the living human brain.
That matters because AMPA receptors are a key part of glutamatergic signaling.
For years researchers have suspected that ketamine’s rapid antidepressant effects depend on them. This study tries to show that directly in humans, not just in animal models.
A new preprint proposes an interesting mechanism for Long COVID - a link between gut dysbiosis - microbial extracellular vesicles - systemic inflammation - neuroinflammation.
This is not just correlation. The authors also test functional models.🧵
The main idea - after SARS-CoV-2 infection, patients may develop a persistent alteration of the gut microbiome. This does not only mean a different bacterial composition, but also the production of different signaling particles - so-called gut microbiota-derived extracellular vesicles (GMEVs).
These vesicles are microscopic membrane particles carrying bacterial cargo. Proteins, lipids, nucleic acids, and other immunologically active molecules. The authors propose that they may transmit inflammatory signals from the gut to the rest of the body.
A new study looked at long-term taste dysfunction after COVID-19.
Researchers combined psychophysical taste tests, biopsies of tongue papillae, and gene-expression analysis in taste cells from patients with persistent symptoms more than a year after infection🧵
One striking observation - in most patients, taste buds were not structurally destroyed. Under the microscope, both taste receptor cells and the nerve fibers that normally innervate them were still present.
Yet many patients had lost the ability to detect specific tastes. The most affected were sweet, umami and bitter - the three taste modalities that share the same intracellular signaling pathway in so-called Type II taste cells.
A very interesting 2026 study compares classic ME/CFS, post-COVID ME/CFS like (PCS-CFS), and MS.
It doesn’t just measure antibodies - it tests their functional effects on cells (in vitro).
And the takeaway? Post-COVID does not look identical🧵
Researchers isolated IgG antibodies from patients and exposed endothelial cells to them.
They analyzed mitochondrial structure, cellular energetics, inflammatory cytokines, immune complex proteomics
This allows biological comparison across groups.
Classic ME/CFS
IgG from a subset of patients induced mitochondrial fragmentation and metabolic adaptation.
This resembles chronic cellular stress - not acute energy failure.
In this group of people who self-identified as having Long COVID and were willing to complete an online survey, Long COVID is very long-lasting - around 20 months after symptom onset, only about 5% were fully back to baseline.🧵
The median duration of symptoms was about 20 months.
Only 5% of patients fully recovered.
About 59% never had a symptom-free day.
Most common course patterns
constant symptoms 45%
fluctuating ~27%
relapsing ~10%